Charts, layoffs, insights and news for Johnson & Johnson MedTech are members-only.Sign in →
New hirings vs layoffs · monthly
Δ = new hirings − layoffs
Hiring detail
Workforce composition · live
Hiring by region · country × title bucket
Layoffs
Strategic insights
Recent news
Date
Type
Headline
February 16, 2026
news
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
This article analyzes J&J's MedTech segment performance in 2025, noting strong growth driven by acquisitions and new product launches in cardiovascular, surgery, and vision markets. It also discusses challenges in China due to the VBP program and potential tariff costs in 2026, while projecting better growth for MedTech in 2026.
December 05, 2025
news
Johnson & Johnson MedTech Sets New Course with Business Unit-Led Structure for 2026
This article reports on J&J MedTech's strategic decision to adopt a fully business unit-led structure starting January 2026. This move aims to enhance decision-making, accountability, and competitiveness, building on a decentralized model initiated in 2024. It also mentions the planned separation of the Orthopaedics business and associated leadership changes.
April 14, 2026
news
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
This article details J&J's strong Q1 2026 financial performance, with significant reported sales growth and increased guidance for the full year. It highlights progress in various therapeutic areas, including MedTech, and mentions strategic approvals and a planned Enterprise Business Review.
2026-06-30
leadership
DePuy Synthes names CFO ahead of J&J split
2026-06-26
product
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-25
leadership
Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform
2026-06-23
leadership
Medtronic appoints veteran J&J exec as first CFO of innovation
2026-05-27
product
John Slump Launches Metis MedTech Following Atraverse Medical Acquisition by Johnson & Johnson